Kezar Life Sciences GAAP EPS of -$0.25
Nov. 10, 2022 5:14 PM ETKezar Life Sciences, Inc. (KZR)By: Urvi Shah, SA News Editor
- Kezar Life Sciences press release (NASDAQ:KZR): Q3 GAAP EPS of -$0.25.
- Cash, cash equivalents and marketable securities totaled $290.4 million as of September 30, 2022, compared to $208.4 million as of December 31, 2021.
- Total shares of common stock outstanding were 68.4 million shares as of September 30, 2022.